Company Filing History:

6 out of 55

Institut Pasteur De Lille

Institut National De La Sante Et De La Recherche Medicale

where one patent can have more than one assignee

Years Active: 1991-2005

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6841358 - RECOMBINANT PROTEINS OF FILAMENTOUS HAEMAGGLUTININ OF BORDETELLA, PARTICULARLY BORDETELLA PERTUSSIS, METHOD FOR PRODUCING SAME, AND USES THEREOF FOR PRODUCING FOREIGN PROTEINS OF VACCINATING ACTIVE PRINCIPLES (2005-01-11),

2. 5824788 - Cloning of gene encoding the GP28.5 protein of toxoplasma gondii; (1998-10-20),

3. 5753236 - Antigenic composition obtained by V8 proteolysis of a protein from S. (1998-05-19),

4. 5597570 - Protein recognized by antibodies raised against native P28 of (1997-01-28),

5. 5279822 - Monoclonal antibodies against the 28KD protein of S. mansoni (1994-01-18),

6. 5071959 - Novel lymphokine for suppressing platelet activation (1991-12-10),

7. 5021560 - Immunogenic fraction active against bilharzioses, its preparation, and (1991-06-04),

Title: The Innovative Contributions of Andre Capron

Introduction

Andre Capron is a notable inventor based in Phalempin, France. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant proteins. With a total of seven patents to his name, Capron's work has had a substantial impact on vaccine development and protein production.

Latest Patents

One of Capron's latest patents is focused on recombinant proteins of filamentous haemagglutinin of Bordetella, particularly Bordetella pertussis. This patent describes a method for producing these proteins and their uses in creating foreign proteins for vaccinating active principles. The invention involves a recombinant DNA sequence that codes for a polypeptide heterologous to a filamentous haemagglutinin, which is crucial for vaccine development. The process allows for the expression and secretion of the Fha protein in cell cultures, facilitating the isolation of the proteins needed for further research and application.

Career Highlights

Throughout his career, Andre Capron has worked with prestigious institutions such as the Institut Pasteur de Lille and the Institut Pasteur. His research has contributed to advancements in the understanding of infectious diseases and the development of effective vaccines. Capron's innovative approaches have positioned him as a key figure in the field of biotechnology.

Collaborations

Capron has collaborated with notable colleagues, including Jean-Marie Grzych and Jean-Marc Balloul. These partnerships have enhanced his research efforts and contributed to the successful development of his patented technologies.

Conclusion

Andre Capron's work exemplifies the spirit of innovation in biotechnology. His contributions to recombinant protein development and vaccine research continue to influence the field significantly. His patents reflect a commitment to advancing scientific knowledge and improving public health through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.